Otto Bock Healthcare Products GmbH
17
2
5
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
11.8%
2 terminated/withdrawn out of 17 trials
81.8%
-4.7% vs industry average
0%
0 trials in Phase 3/4
67%
6 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
C-Brace II Spinal Cord Injury
Role: collaborator
Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain
Role: collaborator
Effectiveness Ankle-7 Orthosis VS HAFO Orthosis on Gait in Diplegic CPChildren
Role: collaborator
1C70 Feasibility Study
Role: lead
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
Role: collaborator
C-Brace Prospective Registry
Role: lead
Feasibility Study to Evaluate a New Energy Storage and Return Prosthetic Foot
Role: lead
Clinical Trial Comparing C-Brace to Knee Ankle Foot Orthosis (KAFO)/Stance Control Orthosis (SCO)
Role: lead
Assessing Outcomes With Microprocessor Knee Utilization in a K2 Population
Role: lead
Early Rehabilitation After Transfemoral Amputation in Moderately Active Patients
Role: collaborator
Clinical Algorithm for Post-Stroke Gait Training With C-Brace
Role: collaborator
C-Leg 3 and C-Leg 4 Study in Transfemoral Amputees
Role: lead
Clinical Study to Evaluate the Implantation of the ActiGait Drop Foot Stimulator System
Role: lead
Microprocessor Knees in Early Rehabilitation
Role: collaborator
EmPOWERing Active Seniors With Energy
Role: lead
Evaluation of the Genu Neurexa Orthosis in Post Stroke Patients
Role: collaborator
Effect of Socket Wall Height With Vacuum Suspension for Above Knee Amputees
Role: collaborator
All 17 trials loaded